000 | 01848 a2200529 4500 | ||
---|---|---|---|
005 | 20250514014716.0 | ||
264 | 0 | _c20020401 | |
008 | 200204s 0 0 eng d | ||
022 | _a0028-1298 | ||
024 | 7 |
_a10.1007/s002100100467 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIalenti, A | |
245 | 0 | 0 |
_aRole of nuclear factor-kappaB in a rat model of vascular injury. _h[electronic resource] |
260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cOct 2001 |
||
300 |
_a343-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAngioplasty, Balloon |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aBlood Vessels _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarotid Arteries _xdrug effects |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 | _aDensitometry |
650 | 0 | 4 | _aElectrophoretic Mobility Shift Assay |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aIsoenzymes _xbiosynthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aPrecipitin Tests |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xbiosynthesis |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aThiocarbamates _xpharmacology |
700 | 1 | _aIanaro, A | |
700 | 1 | _aMaffia, P | |
700 | 1 | _aCarnuccio, R | |
700 | 1 | _aD'Acquisto, F | |
700 | 1 | _aMaiello, F M | |
700 | 1 | _aDi Rosa, M | |
773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 364 _gno. 4 _gp. 343-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002100100467 _zAvailable from publisher's website |
999 |
_c11600428 _d11600428 |